Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11819501 Parenteral unit dosage form of dihydroergotamine
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 29 Nov, 2023
"Created via: Patent importer"
Golden AI
created this topic on 29 Nov, 2023
Edits made to:
Infobox
(
+22
properties)
US Patent 11819501 Parenteral unit dosage form of dihydroergotamine
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11819501
0
Patent Inventor Names
Alpesh Goyani
0
Bhaskar Pallerla
0
Deepak Singodia
0
Rajamannar Thennati
0
Subhas Balaram Bhowmick
0
Sudeep Kumar Agrawal
0
Date of Patent
November 21, 2023
0
Patent Application Number
17712274
0
Date Filed
April 4, 2022
0
Patent Citations
US Patent 9943649 Automatic injection device
0
US Patent 10456531 Injection device
0
US Patent 10532049 Parenteral unit dosage form of dihydroergotamine
0
US Patent 11304942 Parenteral unit dosage form of dihydroergotamine
0
Patent Primary Examiner
Theodore R. Howell
0
CPC Code
A61K 9/08
0
A61K 9/0019
0
A61P 25/06
0
A61K 31/48
0
A61M 5/20
0
Find more entities like US Patent 11819501 Parenteral unit dosage form of dihydroergotamine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE